Erratum: "The first generic tirzepatide GP30931: physicochemical and biological similarity to the reference drug"

I.A. Lugovik; Anna V. Babina; Sergey Arutyunyan; D. О. Ermolaeva; Valeria B. Saparova; T. N. Kobeleva; P. G. Zaikin; A. D. Mikushina; Anton Bukatin; I. E. Eliseev; B. Ts. Zajchik; Y. S. Keruchenko; I. S. Ohrimenko; Е. В. Бочаров; Amir Taldaev; В. Лушпа; I. E. Makarenko; Драй Роман Васильевич

doi:10.33380/2305-2066-2026-15-1-249-250

Erratum: "The first generic tirzepatide GP30931: physicochemical and biological similarity to the reference drug"

Drug development & registration 2026 Open access

Read full text

Authors: I.A. Lugovik, Anna V. Babina, Sergey Arutyunyan, D. О. Ermolaeva, Valeria B. Saparova, T. N. Kobeleva, P. G. Zaikin, A. D. Mikushina, Anton Bukatin, I. E. Eliseev, B. Ts. Zajchik, Y. S. Keruchenko

+6 more

I. S. Ohrimenko, Е. В. Бочаров, Amir Taldaev, В. Лушпа, I. E. Makarenko, Драй Роман Васильевич

DOI: 10.33380/2305-2066-2026-15-1-249-250

Cited by: 0

Abstract

Drug development & registration. 2025;14(2):54–74. (In Russ.) https://doi.org/10.33380/2305-2066-2025-14-2-2084 . Published: 20.05.2025.

Fields of Study & Subjects

Diabetes Treatment and Management Biosimilars and Bioanalytical Methods Analytical Methods in Pharmaceuticals

Publication details

Journal / source: Drug development & registration
Volume: 15
Issue: 1
Pages: 249–250
Publication date: 2 March 2026
Language: EN